Skip to main content
. 2022 Jan-Jun;12(1):10–18. doi: 10.5005/jp-journals-10018-1367

Table 7.

Duration of hospitalization and SARS-CoV-2 negativity in different groups

Variables Mean ± SD p-values (one-tail) p-values (two-tails)
Clinical outcomes mild COVID-19 patients for SOC and SOC ± Euphorbia neriifoliatreatment
Duration of hospital stay-day for mild COVID-19 patients for SOC treatment (control) 17.333 ± 3.416
(17; 10–36)
0.0000** 0.0000**
Duration of hospital stay-day for mild COVID-19 patients for SOC ± E. neriifolia treatment 4.200 ± 1.014
(4; 2–8)
Clinical outcomes moderate COVID-19 patients for SOC and SOC ± Euphorbia neriifoliatreatment
Duration of hospital stay-day for moderate COVID-19 patients for SOC treatment (control) 29.400 ± 8.365
(30; 12–45)
0.0000** 0.0000**
Duration of hospital stay-day for moderate COVID-19 patients for SOC ± E. neriifolia treatment 8.467 ± 3.739
(7; 4–12)

Data are shown as mean ± standard deviation. Statistical significance was considered when p-value was <0.01 and <0.05 and shown as ** and * mark, respectively. p value calculated with 5% level of significance